BiogeniQ

BiogeniQ, a Canadian company founded in 2013, operates at the intersection of healthcare and advanced medical testing, specializing in genetics. Since becoming a subsidiary of the Biron Health Group in its founding year, BiogeniQ has dedicated itself to providing sophisticated DNA testing and personalized health solutions. The company's primary objective is to equip both individuals and medical practitioners with actionable genetic data, thereby enabling more informed decisions regarding disease prevention, treatment efficacy, and overall well-being. Its operations are centered around a single location, emphasizing focused expertise in genetic diagnostics.

The core offerings from BiogeniQ include detailed DNA testing that can detect an individual's predisposition to developing or transmitting genetic diseases, identify drugs that may cause adverse reactions, and offer personalized dietary recommendations aligned with their genetic makeup. BiogeniQ's team of genetic specialists collaborates closely with attending physicians, offering expert guidance to support personalized treatment plans. Meet BiogeniQ's team to understand the expertise driving these critical health services and the scientific rigor applied to each genetic analysis.

BiogeniQ generates substantial revenue, reporting $39.9M, and operates with an employee range of 500-1,000 employees. Its market presence is notable within Canada, competing against various entities in the genetic testing and diagnostics space, including prominent players like EasyDNA and LifeLabs Genetics. The company's B2C focus, supported by its technical capabilities in genetics, positions it as a key contributor to the evolving landscape of personalized medicine and preventative healthcare solutions.